In Bacterial infections Pipli 1.125gm Injection contains two different medicines that work together to kill the bacteria that cause infections. Piperacillin belongs to a group of medicines called penicillins that work by stopping the growth of bacteria. Tazobactam is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Piperacillin against bacteria. Pipli 1.125gm Injection can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Consuming alcohol with Pipli 1.125gm Injection does not cause any harmful side effects.
Pipli 1.125gm Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Pipli 1.125gm Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
It is not known whether Pipli 1.125gm Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Pipli 1.125gm Injection should be used with caution in patients with kidney disease. Dose adjustment of Pipli 1.125gm Injection may be needed. Please consult your doctor.
Pipli 1.125gm Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Pipli 1.125gm Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Pipli 1.125gm Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Godrams Lifeline || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lee Chem Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Samarth Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Caddes Life Sciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nexkem Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Astonea Labs Private Limited || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Venus Remedies Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cachet Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Nest Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tulip Lab Pvt Ltd || ₹14.5/tablet (25% cheaper)